NCT05205980 Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD)
| NCT ID | NCT05205980 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Georgia State University |
| Condition | Alzheimer Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-04-28 |
| Primary Completion | 2026-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2023-04-28 with a primary completion date of 2026-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will examine the overall capacity of people with Alzheimer's disease learning fall-resistant skills from perturbation training.
Eligibility Criteria
Inclusion Criteria: * Participants must be at least 65 years old; * Participants have a clinical diagnosis of probable AD; * Participants can read and understand English; * Participants must be able to walk independently at least 25 feet; * Participants must be able to stand independently for at least 30 seconds; * Participants must have a Montreal Cognitive Assessment score of 11-21 or Mini Mental Status Examination score between 18 and 23. Exclusion Criteria: * Individuals have ever experienced perturbation training; * Individuals have hypotension or uncontrolled hypertension; * Individuals exhibit osteoporosis; * Participants suffer from coexisting psychiatric disorders, or other neurological conditions, or injuries, etc.
Contact & Investigator
Feng Yang, PhD
PRINCIPAL INVESTIGATOR
Georgia State University
Frequently Asked Questions
Who can join the NCT05205980 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 90 Years, studying Alzheimer Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05205980 currently recruiting?
Yes, NCT05205980 is actively recruiting participants. Contact the research team at fyang@gsu.edu for enrollment information.
Where is the NCT05205980 trial being conducted?
This trial is being conducted at Valdosta, United States.
Who is sponsoring the NCT05205980 clinical trial?
NCT05205980 is sponsored by Georgia State University. The principal investigator is Feng Yang, PhD at Georgia State University. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.